2-amino-decanoic acid ; hydrochloride | 5463-27-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-amino-decanoic acid ; hydrochloride
• 英文别名: 2-Amino-decansaeure; Hydrochlorid；2-Aminodecanoic acid;hydrochloride
• CAS: 5463-27-4
• 化学式: C₁₀H₂₁NO₂*ClH
• 分子量: 223.743
• InChiKey: QQBDWIQVXDOZCQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.57
• 重原子数：
  14
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  63.3
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-amino-decanoic acid ; hydrochloride 在 氯化亚砜 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 生成
  参考文献：
  名称：

  Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase

  摘要：

  The soluble epoxide hydrolase (sEH) plays an important role in the metabolism of endogenous chemical mediators involved in blood pressure regulation and vascular inflammation. 12-(3-Adamantan-1-yl-ureido)-dodecanoic acid (AUDA, 1) is a very active inhibitor of sEH both in vitro and in vivo. However, its relatively high melting point and limited solubility in either water or oil-based solvents leads to difficulties in formulating the compound and often results in poor in vivo availability. We investigated the effect of derivatization of the acid functional group of inhibitor I on the inhibition potencies, physical properties, and pharmacokinetic properties. For human sEH, similar inhibition potency was obtained when the acid of compound I was modified to esters (2-15). The resulting compounds exhibited improved physical properties (23-66 degrees C lower melting point and 5-fold better solubility in oil). Pharmacokinetic studies showed that the esters possess improved oral bioavailability in mice. On the other hand, amide derivatives of AUDA I did not show significant improvement in inhibition potencies or physical properties (higher melting points and lower solubility). The esterification of 1 results in compounds that are easier to formulate in animal food and in triglycerides for gavage and other routes of administration, making it easier to study the biological effects of sEH inhibition in vivo. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2006.09.057
• 作为产物：
  描述：

  acetylamino-octyl-malonic acid diethyl ester 在 盐酸 作用下， 生成 2-amino-decanoic acid ; hydrochloride
  参考文献：
  名称：

  Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis

  摘要：

  Lipidic alpha-amino acids (LAAs) have been described as non-natural amino acids with long saturated or unsaturated aliphatic chains. In the continuing prospect to discover anticancer agents from marine sources, we have obtained a mixture of two cytotoxic LAAs (1a and 1b) from the zoanthid Protopalythoa variabilis. The anti-proliferative potential of 14 synthetic LAAs and 1a/1b were evaluated on four tumor cell lines (HCT-8, SF-295, MDA-MB-435, and HL-60). Five of the synthetic LAAs showed high percentage of tumor cell inhibition, while 1a/1b completely inhibited tumor cell growth. Additionally, apoptotic effects of 1a/1b were studied on HL-60 cell line. 1a/1b-treated cells showed apoptosis morphology, loss of mitochondrial potential, and DNA fragmentation. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.09.027

文献信息

• Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis
  作者：Diego Veras Wilke、Paula Christine Jimenez、Renata Mendonça Araújo、Wildson Max Barbosa da Silva、Otília Deusdênia Loiola Pessoa、Edilberto Rocha Silveira、Claudia Pessoa、Manoel Odorico de Moraes、Mariusz Skwarczynski、Pavla Simerska、Istvan Toth、Letícia Veras Costa-Lotufo

  DOI：10.1016/j.bmc.2010.09.027

  日期：2010.11

  Lipidic alpha-amino acids (LAAs) have been described as non-natural amino acids with long saturated or unsaturated aliphatic chains. In the continuing prospect to discover anticancer agents from marine sources, we have obtained a mixture of two cytotoxic LAAs (1a and 1b) from the zoanthid Protopalythoa variabilis. The anti-proliferative potential of 14 synthetic LAAs and 1a/1b were evaluated on four tumor cell lines (HCT-8, SF-295, MDA-MB-435, and HL-60). Five of the synthetic LAAs showed high percentage of tumor cell inhibition, while 1a/1b completely inhibited tumor cell growth. Additionally, apoptotic effects of 1a/1b were studied on HL-60 cell line. 1a/1b-treated cells showed apoptosis morphology, loss of mitochondrial potential, and DNA fragmentation. (C) 2010 Elsevier Ltd. All rights reserved.
• Corrigendum to “Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis” [Bioorg. Med. Chem. 18 (2010) 7997–8004]
  作者：Diego Veras Wilke、Paula Christine Jimenez、Renata Mendonça Araújo、Wildson Max Barbosa da Silva、Otília Deusdênia Loiola Pessoa、Edilberto Rocha Silveira、Claudia Pessoa、Manoel Odorico de Moraes、Mariusz Skwarczynski、Pavla Simerska、Istvan Toth、Letícia Veras Costa-Lotufo

  DOI：10.1016/j.bmc.2010.12.041

  日期：2011.2
• Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase
  作者：In-Hae Kim、Kosuke Nishi、Hsing-Ju Tsai、Tanya Bradford、Yasuko Koda、Takaho Watanabe、Christophe Morisseau、Joanne Blanchfield、Istvan Toth、Bruce D. Hammock

  DOI：10.1016/j.bmc.2006.09.057

  日期：2007.1.1

  The soluble epoxide hydrolase (sEH) plays an important role in the metabolism of endogenous chemical mediators involved in blood pressure regulation and vascular inflammation. 12-(3-Adamantan-1-yl-ureido)-dodecanoic acid (AUDA, 1) is a very active inhibitor of sEH both in vitro and in vivo. However, its relatively high melting point and limited solubility in either water or oil-based solvents leads to difficulties in formulating the compound and often results in poor in vivo availability. We investigated the effect of derivatization of the acid functional group of inhibitor I on the inhibition potencies, physical properties, and pharmacokinetic properties. For human sEH, similar inhibition potency was obtained when the acid of compound I was modified to esters (2-15). The resulting compounds exhibited improved physical properties (23-66 degrees C lower melting point and 5-fold better solubility in oil). Pharmacokinetic studies showed that the esters possess improved oral bioavailability in mice. On the other hand, amide derivatives of AUDA I did not show significant improvement in inhibition potencies or physical properties (higher melting points and lower solubility). The esterification of 1 results in compounds that are easier to formulate in animal food and in triglycerides for gavage and other routes of administration, making it easier to study the biological effects of sEH inhibition in vivo. (c) 2006 Elsevier Ltd. All rights reserved.